Filing Details
- Accession Number:
- 0001209191-22-058910
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-28 20:29:09
- Reporting Period:
- 2022-11-23
- Accepted Time:
- 2022-11-28 20:29:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496323 | Igm Biosciences Inc. | IGMS | Pharmaceutical Preparations (2834) | 770349194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787362 | Bruce Keyt | C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-23 | 600 | $21.38 | 38,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-23 | 277 | $21.99 | 38,612 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,013 | Indirect | See footnote |
Footnotes
- These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- The shares are held directly by the reporting person's spouse.
Billionaire Hedge Funds
